DENTSPLY Sirona Inc (XRAY) concluded trading on Thursday at a closing price of $15.64, with 2.81 million shares of worth about $44.02 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -40.05% during that period and on March 27, 2025 the price saw a gain of about 0.26%. Currently the company’s common shares owned by public are about 198.80M shares, out of which, 197.66M shares are available for trading.
Stock saw a price change of 0.26% in past 5 days and over the past one month there was a price change of -16.85%. Year-to-date (YTD), XRAY shares are showing a performance of -17.60% which decreased to -52.38% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $14.77 but also hit the highest price of $33.42 during that period. The average intraday trading volume for DENTSPLY Sirona Inc shares is 2.77 million. The stock is currently trading -0.85% below its 20-day simple moving average (SMA20), while that difference is down -11.60% for SMA50 and it goes to -28.63% lower than SMA200.
DENTSPLY Sirona Inc (NASDAQ: XRAY) currently have 198.80M outstanding shares and institutions hold larger chunk of about 102.66% of that.
The stock has a current market capitalization of $3.11B and its 3Y-monthly beta is at 0.92. It has posted earnings per share of -$4.55 in the same period. It has Quick Ratio of 0.74 while making debt-to-equity ratio of 1.17. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for XRAY, volatility over the week remained 2.30% while standing at 3.84% over the month.
Stock’s fiscal year EPS is expected to rise by 9.21% while it is estimated to increase by 11.52% in next year.
Coverage by Wells Fargo stated DENTSPLY Sirona Inc (XRAY) stock as an Equal weight in their note to investors on February 14, 2025, suggesting a price target of $20 for the stock. On January 23, 2025, Jefferies Downgrade their recommendations, while on January 07, 2025, Evercore ISI Downgrade their ratings for the stock with a price target of $20. Stock get a Neutral rating from Mizuho on December 04, 2024.
